Rocket will also collaborate with investigators to implement an immunomodulatory regimen more closely reflecting that administered in the Phase 1 pediatric cohort
The randomized, double-blind, placebo-controlled Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102 in healthy participants
Medical plastics make up about 25 per cent of the 14,000 tons of waste generated daily in US healthcare facilities
FDA grants accelerated approval to zongertinib for HER2 TKD-Mutated Non-Squamous NSCLC
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Norepinephrine Bitartratein 5% Dextrose of Baxter Healthcare Corp
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
Innovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR and ADC research
The operating profit (EBITDA) rose 20.7% to Rs. 156.4 crore
Athena is also exploring the use of this technology for expanded carrier screening
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
Subscribe To Our Newsletter & Stay Updated
